Japan‐specific subtype of hepatitis C virus genotype 1b, J subtype, has relatively low pathogenicity

The prognostic implication of viral genotype 1b for hepatitis C virus (HCV) infection has been controversial, possibly due to the pathogenetic heterogeneity of genotype 1b. We analyzed two newly delineated subtypes of HCV genotype 1b subtypes with respect to progression of liver disease. Patients with chronic HCV 1b infection (113 total, including 18 with chronic persistent hepatitis, 60 with chronic active hepatitis, 19 with cirrhosis, and 16 with hepatocellular carcinoma with cirrhosis) were studied to elucidate the factors associated with progression of liver disease. Factors evaluated included sex, age at diagnosis, blood transfusion history, and HCV genotype 1b subtype (W subtype or J subtype). W subtype was identified more often in association with chronic active hepatitis than with chronic persistent hepatitis (P = 0.0089), and more often in patients with cirrhosis than in those without (P = 0.0044). The age‐, sex‐, and transfusion history‐adjusted odds ratios with respect to histological activity and presence of cirrhosis for W subtype compared to J subtype were 6.966 (1.856 to 26.145) and 6.397 (1.506 to 27.179), respectively. Age at diagnosis was the most important risk factor for predicting development of cirrhosis and carcinoma. In conclusion, the W subtype of HCV 1b is associated closely with histologically active disease and development of cirrhosis, whereas the Japan‐specific J subtype has relatively low pathogenicity. HCV genotype 1b, therefore, is heterogeneous in its pathogenicity. J. Med. Virol. 65:45–51, 2001. © 2001 Wiley‐Liss, Inc.

[1]  A. Widell,et al.  The importance of cofactors in the histologic progression of minimal and mild chronic hepatitis C. , 2008, Liver.

[2]  J. Hoofnagle,et al.  Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C , 2000, Annals of Internal Medicine.

[3]  J. Kench,et al.  Which patients with hepatitis C develop liver complications? , 2000, Hepatology.

[4]  T. Hayakawa,et al.  Why is the interferon sensitivity-determining region (ISDR) system useful in Japan? , 1999, Journal of hepatology.

[5]  K. Okita,et al.  Factors predicting progression to cirrhosis and hepatocellular carcinoma in patients with transfusion-associated hepatitis C virus infection. , 1999, Journal of clinical gastroenterology.

[6]  J. Córdoba,et al.  High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: Relationship with rejection episodes , 1999, Hepatology.

[7]  D. Häussinger,et al.  Prognosis of chronic hepatitis c: Results of a large, prospective cohort study , 1998, Hepatology.

[8]  H. Tsukuma,et al.  Hepatitis C virus 1b(II) infection and development of chronic hepatitis, liver cirrhosis and hepatocellular carcinoma: a case-control study in Japan. , 1998, Journal of epidemiology.

[9]  G. Dusheiko,et al.  The natural course of chronic hepatitis C: implications for clinical practice , 1998, Journal of viral hepatitis.

[10]  M. Rapicetta,et al.  Correlation between virus genotype and chronicity rate in acute hepatitis C. , 1998, Journal of hepatology.

[11]  O. Chazouilleres,et al.  Determinants of outcome of compensated hepatitis C virus‐related cirrhosis , 1998, Hepatology.

[12]  Edoardo Cervoni,et al.  Hepatitis C , 1998, The Lancet.

[13]  J. Bruix,et al.  Hepatitis C virus (HCV) genotypes in Spanish patients with HCV infection: relationship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma. , 1997, Journal of hepatology.

[14]  A. Andriulli,et al.  HCV genotypes in patients with liver disease of different stages and severity. , 1997, Journal of hepatology.

[15]  L. Stuyver,et al.  Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence do not predict the response to recombinant interferon-alfa therapy in French patients. , 1997, Journal of hepatology.

[16]  K. Batts,et al.  Relationship between hepatitis C genotype and severity of recurrent hepatitis C after liver transplantation. , 1997, Transplantation.

[17]  P. Bedossa,et al.  Natural history of liver fibrosis progression in patients with chronic hepatitis C , 1997, The Lancet.

[18]  S. Zeuzem,et al.  Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa , 1997, Hepatology.

[19]  M. Mondelli,et al.  Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: A prospective study , 1997, Hepatology.

[20]  P. Simmonds,et al.  The origin of hepatitis C virus genotypes. , 1997, The Journal of general virology.

[21]  A. Alberti,et al.  Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus‐related cirrhosis , 1997, Hepatology.

[22]  C. Kim,et al.  Hepatitis C Virus Genotypes in Korea and Their Relationship to Clinical Outcome in Type C Chronic Liver Diseases , 1997, The Korean journal of internal medicine.

[23]  D. Trichopoulos,et al.  Hepatitis C virus 1b is the dominant genotype in HCV‐related carcinogenesis: A case‐control study , 1996, International journal of cancer.

[24]  E. Tanaka,et al.  The natural course of chronic hepatitis C: A comparison between patients with genotypes 1 and 2 hepatitis C viruses , 1996, Hepatology.

[25]  B. Portmann,et al.  Long-term outcome of hepatitis C infection after liver transplantation. , 1996, The New England journal of medicine.

[26]  T. Matsushima,et al.  Relationship between hepatocellular carcinoma and subtypes of hepatitis C virus: A nationwide analysis , 1996, Journal of gastroenterology and hepatology.

[27]  M A Gerber,et al.  Histological classification and quantitation of the severity of chronic hepatitis: keep it simple! , 1995, Seminars in liver disease.

[28]  E. Schiff,et al.  Hepatitis C virus in alcoholic patients with and without clinically apparent liver disease. , 1995, Alcoholism, clinical and experimental research.

[29]  N. Enomoto,et al.  Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. , 1995, The Journal of clinical investigation.

[30]  V. Paradis,et al.  Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. , 1995, Gastroenterology.

[31]  O. Yokosuka,et al.  Incidence of hepatocellular carcinoma in chronic hepatitis B and C: A prospective study of 251 patients , 1995, Hepatology.

[32]  Paul Landais,et al.  Hepatitis C Virus Type 1b (II) Infection in France and Italy , 1995, Annals of Internal Medicine.

[33]  M. Mondelli,et al.  Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities , 1995, Hepatology.

[34]  R. Purcell,et al.  Genetic Heterogeneity of Hepatitis C Virus: Quasispecies and Genotypes , 1995, Seminars in liver disease.

[35]  M. Honda,et al.  Degree of diversity of hepatitis C virus quasispecies and progression of liver disease , 1994, Hepatology.

[36]  Kenichi Kobayashi,et al.  Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease , 1994, Journal of medical virology.

[37]  N. Hayashi,et al.  Hepatitis C virus genotype and RNA titer in the progression of type C chronic liver disease. , 1994, Journal of hepatology.